Analysis of Critical Parameters for Radioiodine Remnant Ablation in Patients with Differentiated Thyroid Carcinoma

被引：0
|
作者：
Mika, A. Valkovic [1 ]
Nekic, J. [1 ]
Ivankovic, S. Grbac [1 ]
Valkovic, A. [1 ]
机构：
[1] Clin Hosp, Ctr Rijeka, Rijeka, Croatia
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2012年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P0606
引用
收藏
页码：S482 / S482
页数：1
相关论文
共 50 条
  • [21] Radioiodine uptake by thyroglossal duct remnant after radioiodine therapy for differentiated thyroid carcinoma
    Jinguji, M.
    Nakajo, M.
    Tani, A.
    Yoshiura, T.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S783 - S784
  • [22] Could short thyroid hormone withdrawal be an effective strategy for radioiodine remnant ablation in differentiated thyroid cancer patients?
    Piccardo, Arnoldo
    Puntoni, Matteo
    Ferrarazzo, Giulia
    Foppiani, Luca
    Bottoni, Gianluca
    Altrinetti, Vania
    Treglia, Giorgio
    Naseri, Mehrdad
    Dib, Bassam
    Cabria, Manlio
    Trimboli, Pierpaolo
    Massollo, Michela
    Giovanella, Luca
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (07) : 1218 - 1223
  • [23] Could short thyroid hormone withdrawal be an effective strategy for radioiodine remnant ablation in differentiated thyroid cancer patients?
    Arnoldo Piccardo
    Matteo Puntoni
    Giulia Ferrarazzo
    Luca Foppiani
    Gianluca Bottoni
    Vania Altrinetti
    Giorgio Treglia
    Mehrdad Naseri
    Bassam Dib
    Manlio Cabria
    Pierpaolo Trimboli
    Michela Massollo
    Luca Giovanella
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 1218 - 1223
  • [24] Low Radioiodine Dose in Postoperative Ablation of Residual Thyroid Tissue in Patients with Differentiated Thyroid Carcinoma
    Bourogianni, O.
    Kapsoritakis, N.
    Tsaroucha, A.
    Stahaki, M.
    Papadaki, E.
    Koukouraki, S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S437 - S437
  • [25] Outcomes comparison of thyroxine withdrawal of 2 weeks and 3 weeks for radioiodine remnant ablation of differentiated thyroid carcinoma
    Wang, Yueqi
    Huang, Rui
    Li, Lin
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [26] Low dose radioiodine activity for ablation after thyroidectomy in patients with differentiated thyroid carcinoma
    Henao Celada, Y. K.
    Gomez Fernandez, I.
    Duran Barquero, C.
    Ardila Manjarres, J.
    Ardila Mantilla, J.
    Lozano Murgas, L.
    Zamudio, D.
    Rotger Regi, A.
    Alonso Farto, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S610 - S611
  • [27] Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients
    Castagna, M. G.
    Cantara, S.
    Pacini, F.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (10) : 1087 - 1094
  • [28] Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients
    M. G. Castagna
    S. Cantara
    F. Pacini
    [J]. Journal of Endocrinological Investigation, 2016, 39 : 1087 - 1094
  • [29] Radioiodine-remnant ablation in low-risk differentiated thyroid cancer: pros
    Ain, Kenneth B.
    [J]. ENDOCRINE, 2015, 50 (01) : 61 - 66
  • [30] Radioiodine-remnant ablation in low-risk differentiated thyroid cancer: pros
    Kenneth B. Ain
    [J]. Endocrine, 2015, 50 : 61 - 66
12345